Newsroom

News

Scientists from the Helmholtz Centre for Infection Research (HZI) in Braunschweig are simulating the effect of various conditions on the development of the SARS-CoV-2 epidemic in Germany. Their results suggest that the restrictions in social life are effective and that a further slowing of the spread is possible. In order to protect the health system from overload, they urgently warn against easing the restrictions already now. They have published their preliminary results, which have not yet been peer-reviewed, on a preprint server for quick scientific use.

08.04.2020

HZI Campus

News

An interdisciplinary group of renowned scientists - among them Prof Gérard Krause, head of the Department Epidemiology at the Helmholtz Centre for Infection Research (HZI) in Braunschweig - is now calling for the current restrictions in society and the economy to be gradually eased, while ensuring medical care for the entire population.

04.04.2020

HZI Campus

News

The Covid-19 pandemic affects more and more countries worldwide. Since the virus causes no or only mild symptoms in many infected people, researchers assume that the number of unreported cases is high. In order to slow down the further spread of the virus, health authorities are focusing on consistent management of contact persons of confirmed cases of infection. For this purpose, the German Public Health Service (ÖGD) will be able to use a special version of the SORMAS disease control app in the future.

01.04.2020

HZI Campus

News

27.03.2020

HZI Campus

News

After an infection with the coronavirus SARS-CoV-2, patients have antibodies against the pathogen in their blood. These are retained over a long period of time and are an indication for a past infection. It is assumed that patients who have recovered from the Covid-19 disease cannot be re-infected with SARS-CoV-2. To date, no data are available on whether there is an unrecognized Covid-19 immunity in the population beyond the SARS-CoV-2 infections recorded. The Helmholtz Centre for Infection Research (HZI) in Braunschweig is now coordinating a study to investigate this question. Anonymous sera from more than 100,000 donors will be analyzed in the population study. The blood will be regularly tested for antibodies against the Covid-19 pathogen. The study will provide a more accurate picture of immunity and pandemic development.

27.03.2020

HZI Campus

News

The new coronavirus SARS-CoV-2 has been identified as the pathogen behind the COVID-19 pandemic. The virus contains a main protease termed Mpro (or also termed 3CLpro), which is involved in the development of the virus’ replication complex. It consequently forms a part of the virus’ replication process and is an attractive drug target. A research group led by Prof. Rolf Hilgenfeld at Lübeck University and the German Center for Infection Research (DZIF) has now determined the protease’s crystal structure.

20.03.2020

HZI Campus

Back to the first page
...
66
67
68
69
...
150

HZI in the media

tools.” – Dr. Anya Sharma, Virologist at the Helmholtz Centre for Infection Research.

Looking Ahead: The Long-Term Implications of

08.01.2026

ARCHYDE

Beisel at Germany's Helmholtz Institute for RNA-based Infection Research in Würzburg and Dirk Heinz at the Helmholtz Center for Infection

07.01.2026

News Medical

... basierte Infektionsforschung (HIRI) in Würzburg nachweisen. Gemeinsam mit dem Braunschweiger Helmholtz-Zentrum für Infektionsforschung ...

07.01.2026

DeutschesGesundheitsPortal

consisting of Hannover Medical School (MHH), the Helmholtz Centre for Infection Research (HZI) in Braunschweig, and the Leibniz Institute in

07.01.2026

Trading View

... haben nun die Studienautoren vom HIRI ‒ einem Standort des Braunschweiger Helmholtz-Zentrums für Infektionsforschung (HZI) in ...

02.01.2026

Biermann Medizin

... bis zur Medikamentenentwicklung", sagt Josef Penninger, wissenschaftlicher Geschäftsführer des HZI und Leiter der Abteilung Innovative ...

30.12.2025

Tagesschau

Erkrankungen. Eine Arbeitsgruppe des TWINCORE Helmholtz Zentrum für Infektionsforschung ( HZI ) und der Medizinischen Hochschule Hannover ( ...

30.12.2025

Deutsches Ärzteblatt

Forschungsteam um Tobias Gulder, Abteilungsleiter am Helmholtz-Institut für Pharmazeutische Forschung Saarland (HIPS), ist es ...

29.12.2025

Biermann Medizin

... des Leibniz Lungenzentrums Borstel, des Helmholtz-Instituts für Pharmazeutische Forschung Saarland sowie weiterer wissenschaftlicher ...

29.12.2025

Das PTA Magazin

Dr. Rolf Müller, Managing Director of Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), were both named laureates of the

22.12.2025

Research Information

... ein Interview mit Josef Penninger geführt . Er ist wissenschaftlicher Geschäftsführer des Helmholtz-Zentrum für Infektionsforschung in ...

21.12.2025

T3N

Forschende vom Würzburger Helmholtz-Institut für RNA-basierte Infektionsforschung (HIRI), einem Standort des Braunschweiger Helmholtz- ...

17.12.2025

Verband Deutscher Biologen e.V.

Register now for the HZI-Newsletter

and stay up to date!

Email address *

We use rapidmail to send our newsletter. I agree that my data entered here will be transmitted to rapidmail. I have taken note of the HZI's privacy policy and have been informed of my rights.